Joseph Clark - Publications

Affiliations: 
University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Pereira JA, Lanzar Z, Clark JT, Hart AP, Douglas BB, Shallberg L, O'Dea K, Christian DA, Hunter CA. PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis. Frontiers in Immunology. 14: 997376. PMID 36960049 DOI: 10.3389/fimmu.2023.997376  0.729
2023 Clark JT, Weizman OE, Aldridge DL, Shallberg LA, Eberhard J, Lanzar Z, Wasche D, Huck JD, Zhou T, Ring AM, Hunter CA. IL-18BP mediates the balance between protective and pathological immune responses to Toxoplasma gondii. Cell Reports. 42: 112147. PMID 36827187 DOI: 10.1016/j.celrep.2023.112147  0.54
2022 Christian DA, Adams TA, Shallberg LA, Phan AT, Smith TE, Abraha M, Perry J, Ruthel G, Clark JT, Pritchard GH, Aronson LR, Gossa S, McGavern DB, Kedl RM, Hunter CA. cDC1 coordinate innate and adaptive responses in the omentum required for T cell priming and memory. Science Immunology. 7: eabq7432. PMID 36179012 DOI: 10.1126/sciimmunol.abq7432  0.688
2022 Perry JA, Shallberg L, Clark JT, Gullicksrud JA, DeLong JH, Douglas BB, Hart AP, Lanzar Z, O'Dea K, Konradt C, Park J, Kuchroo JR, Grubaugh D, Zaretsky AG, Brodsky IE, et al. PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection. Nature Immunology. PMID 35437326 DOI: 10.1038/s41590-022-01170-w  0.627
2021 Dumaine JE, Sateriale A, Gibson AR, Reddy AG, Gullicksrud JA, Hunter EN, Clark JT, Striepen B. The enteric pathogen exports proteins into the cytosol of the infected host cell. Elife. 10. PMID 34866573 DOI: 10.7554/eLife.70451  0.707
2021 Clark JT, Christian DA, Gullicksrud JA, Perry JA, Park J, Jacquet M, Tarrant JC, Radaelli E, Silver J, Hunter CA. IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to . Elife. 10. PMID 33929319 DOI: 10.7554/eLife.65614  0.65
2021 Moore TV, Scurti GM, DeJong M, Wang SY, Dalheim AV, Wagner CR, Hutchens KA, Speiser JJ, Godellas CV, Fountain C, Fleser J, Moudgil T, Thomas M, Murray D, Curti BD, ... Clark JI, et al. HDAC inhibition prevents transgene expression downregulation and loss-of-function in T-cell-receptor-transduced T cells. Molecular Therapy Oncolytics. 20: 352-363. PMID 33614916 DOI: 10.1016/j.omto.2021.01.014  0.393
2020 Chen L, Christian DA, Kochanowsky JA, Phan AT, Clark JT, Wang S, Berry C, Oh J, Chen X, Roos DS, Beiting DP, Koshy AA, Hunter CA. The Toxoplasma gondii virulence factor ROP16 acts in cis and trans, and suppresses T cell responses. The Journal of Experimental Medicine. 217. PMID 31961916 DOI: 10.1084/Jem.20181757  0.736
2017 Moore T, Wagner CR, Scurti GM, Hutchens KA, Godellas C, Clark AL, Kolawole EM, Hellman LM, Singh NK, Huyke FA, Wang SY, Calabrese KM, Embree HD, Orentas R, Shirai K, ... ... Clark JI, et al. Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells. Cancer Immunology, Immunotherapy : Cii. PMID 29052782 DOI: 10.1007/S00262-017-2073-0  0.368
2016 Klarquist J, Tobin K, Farhangi Oskuei P, Henning SW, Fernandez MF, Dellacecca ER, Navarro FC, Eby JM, Chatterjee S, Mehrotra S, Clark JI, Le Poole IC. CCL22 DIVERTS T REGULATORY CELLS AND CONTROLS THE GROWTH OF MELANOMA. Cancer Research. PMID 27634754 DOI: 10.1158/0008-5472.CAN-16-0618  0.319
2009 Loftspring MC, McDole J, Lu A, Clark JF, Johnson AJ. Intracerebral hemorrhage leads to infiltration of several leukocyte populations with concomitant pathophysiological changes Journal of Cerebral Blood Flow and Metabolism. 29: 137-143. PMID 18827833 DOI: 10.1038/jcbfm.2008.114  0.306
2003 Lathers DM, Clark JI, Achille NJ, Young MR. Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. Cancer Immunology, Immunotherapy : Cii. 53: 422-30. PMID 14648070 DOI: 10.1007/s00262-003-0459-7  0.302
Show low-probability matches.